Immunoglobulin light chain repertoire in chronic lymphocytic leukemia

被引:85
作者
Stamatopoulos, K
Belessi, C
Hadzidimitriou, A
Smilevska, T
Kalagiakou, E
Hatzi, K
Stavroyianni, N
Athanasiadou, A
Tsompanakou, A
Papadaki, T
Kokkini, G
Paterakis, G
Saloum, R
Laoutaris, N
Anagnostopoulos, A
Fassas, A
机构
[1] G Papanicolaou Hosp, Dept Hematol, Thessaloniki, Greece
[2] G Papanicolaou Hosp, HCT Unit, Thessaloniki, Greece
[3] Nikea Gen Hosp, Dept Hematol, Piraeus, Greece
[4] Evangelismos Med Ctr, Hemopathol Dept, Athens, Greece
[5] Sismanogle Hos, Dept Hematol, Athens, Greece
[6] G Gennimatas Hosp, Dept Immunol, Athens, Greece
关键词
D O I
10.1182/blood-2005-04-1511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immunoglobulin kappa (IGK) and immunoglobulin lambda (IGL) light chain repertoire was analyzed in 276 chronic lymphocytic leukemia (CLL) cases and compared with the relevant repertoires from normal, autoreactive, and neoplastic cells. Twenty-one functional IGKV genes were used in IGKV-J rearrangements of 179 kappa-CLL cases; the most frequent genes were IGKV3-20(A27), IGKV1-39/1D-39(O2/O12), IGKV1-5(L12), IGKV4-1(B3), and IGKV2-30(A17); 90 (50.3%) of 179 IGK sequences were mutated (similarity < 98%). Twenty functional IGLV genes were used in IGLV-J rearrangements of 97 lambda-CLL cases; the most frequent genes were IGLV3-21(VL2-14), IGLV2-8(VL1-2), and IGLV2-14(VL1-4); 44 of 97 IGL sequences (45.4%) were mutated. Subsets with "CLL-biased" homologous complementarity-determining region 3 (CDR3) were identified: (1) IGKV2-30-IGKJ2, 7 sequences with homologous kappa CDR3 (KCDR3), 5 of 7 associated with homologous IGHV4-34 heavy chains; (2) IGKV1-39/1D39-IGKJ1/4, 4 unmutated sequences with homologous KCDR3, 2 of 4 associated with homologous IGHV4-39 heavy chains; (3) IGKV1-5-IGKJ1/3, 4 sequences with homologous KCDR3, 2 of 4 associated with unmutated nonhomologous IGHV4-39 heavy chains; (4) IGLV1-44-IGLJ2/3, 2 sequences with homologous lambda CDR3 (LCDR3), associated with homologous IGHV4-b heavy chains; and (5) IGLV3-21-IGLJ2/3, 9 sequences with homologous LCDR3, 3 of 9 associated with homologous IGHV3-21 heavy chains. The existence of subsets that comprise given IGKV-J/IGLV-J domains associated with IGHV-D-J domains that display homologous CDR3 provides further evidence for the role of antigen in CLL pathogenesis.
引用
收藏
页码:3575 / 3583
页数:9
相关论文
共 83 条
[61]   Human monoclonal autoantibodies to B-cell epitopes outside the thyroid peroxidase autoantibody immunodominant region [J].
Pichurin, P ;
Guo, J ;
Yan, XM ;
Rapoport, B ;
McLachlan, SM .
THYROID, 2001, 11 (04) :301-313
[62]  
PORTOLANO S, 1993, J IMMUNOL, V151, P2839
[63]   B-LYMPHOCYTES MAY ESCAPE TOLERANCE BY REVISING THEIR ANTIGEN RECEPTORS [J].
RADIC, MZ ;
ERIKSON, J ;
LITWIN, S ;
WEIGERT, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :1165-1173
[64]  
RASSENTI LZ, 1991, J IMMUNOL, V147, P1060
[65]   Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes [J].
Rosner, K ;
Winter, DB ;
Tarone, RE ;
Skovgaard, GL ;
Bohr, VA ;
Gearhart, PJ .
IMMUNOLOGY, 2001, 103 (02) :179-187
[66]  
Shiokawa S, 1999, J IMMUNOL, V162, P6060
[67]   The V4-34 encoded anti-i autoantibodies recognize a large subset of human and mouse B-cells [J].
Silberstein, LE ;
George, A ;
Durdik, JM ;
Kipps, TJ .
BLOOD CELLS MOLECULES AND DISEASES, 1996, 22 (13) :126-138
[68]  
STAMATOPOULOS K, 2005, MOL MED
[69]   Chronic lymphocytic leukemia: revelations from the B-cell receptor [J].
Stevenson, FK ;
Caligaris-Cappio, F .
BLOOD, 2004, 103 (12) :4389-4395
[70]   PRODUCTION OF AUTOANTIBODIES BY CD5-EXPRESSING LYMPHOCYTES-B FROM PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
STHOEGER, ZM ;
WAKAI, M ;
TSE, DB ;
VINCIGUERRA, VP ;
ALLEN, SL ;
BUDMAN, DR ;
LICHTMAN, SM ;
SCHULMAN, P ;
WEISELBERG, LR ;
CHIORAZZI, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) :255-268